Biomin® IMB 52 obtains EU authorization

16-01-2007 | |
Biomin® IMB 52 obtains EU authorization

Biomin® IMB 52, a microbial feed additive based on a single strain of Enterococcus faecium DSM 3530 has gained EU registration for chicken.

The results of three growth trials provided evidence that the inclusion of
Enterococcus faecium Biomin® IMB 52 in complete feed improves weight gain
of chickens. Also the FEEDAP Panel considered the product safe for the target
animals, the consumer, user and the environment.

MIC values for the
tested antibiotics were below the FEEDAP breakpoints indicating the absence of
resistance against antibiotics of human and veterinary importance. The E.
faecium
DSM 3530 was shown free from known virulence
determinants.

Beneficial gut flora
Biomin® IMB 52 is
part of the existing Biomin probiotic products Biomin® C-EX and Biomin® IMBO.
All these products are based on natural raw materials combining the beneficial
effects of probiotics, prebiotics and immune-stimulating substances and are used
particularly in the diets of young animals to help establish a healthy gut and
support the unspecific immune-system.
The probiotic Biomin® IMB 52 helps to
establish and stabilise a beneficial gut microflora and to prevent pathogen
colonization due to fast proliferation, colonization and acidification in the
gut. The immune-stimulating components enhance the innate immune system and thus
improve the resistance to infections. The beneficial gut micro-flora is
additionally supported by the prebiotic component in the products. Young animals
will be more resistant against invading pathogenic bacteria and thus to enteric
disease.

Correspondents



2/3 articles remaining | Register to continue reading.